How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
A Phase 2, Open-label, Non-randomized, Single Center Study to Explore Diagnostic Performance of [18F]fluoroestradiol (FES) Positron Emission Tomography/computed Tomography for the Assessment of Axillary Lymph Node Metastasis in Estrogen-positive Breast Cancer
Description:
This study aims to explore the diagnostic performance of [18F]FES PET/CT for the evaluation of axillary lymph node metastasis in patients with ER-positive breast cancer having clinically suspected or confirmed axillary lymph node metastasis.
Sponsor:
Asan Medical Center
Contacts:
Sangwon Hanhswon87@amc.seoul.kr
+82-2-3010-0657
Jaeeun Kimkje0216@amc.seoul.kr
+82-2-3010-4572
Government Study Link:
NCT06695039 - Click here to see study onClinicalTrials.gov
[18F]FES
Isotope(s):
Target(s):
- 17β-estradiol
